SPOTLIGHT: The best pharma stocks of 2007

 
When it comes to picking stocks, prediction may be murky, but hindsight is crystal clear. We looked at every company in the Wall Street Journal's pharma sector (plus a few others of our own choice), comparing their stock prices on January 1 and December 31, 2007. Then we ranked those companies by percentage increase in stock price. If we'd had the same info at the beginning of last year, these are the 15 stocks we would have chosen. Check out this list of the best pharma stocks of 2007. Report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

The agency has granted Tecentriq a priority review in previously untreated NSCLC, setting up the Roche drug for an approval decision by June 19.

Warren Buffett's Berkshire Hathaway has built a $192 million stake in Biogen, a risky investment considering aducanumab's uncertain future.